Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More

globenewswire.com
TMO Mentioned as a key market participant in the growing cell and gene therapy tools and reagents market, indicating its involvement in a sector with strong projected growth. DHR Mentioned as the parent company of Cytiva, a key participant in the expanding cell and gene therapy tools and reagents market, suggesting its indirect involvement in a high-growth sector. MRK Identified as a key market participant in the cell and gene therapy tools and reagents sector, which is projected to experience significant growth.

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Tools and Reagents: Global Markets" has been added to ResearchAndMarkets.com's offering.

The global market for cell and gene therapy tools and reagents is projected to expand significantly, with figures estimated to rise from $12 billion in 2025 to $19.8 billion by the close of 2030, reflecting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth underscores the increasing importance of cell and gene therapies (CGTs), which represent promising methods in precision medicine for treating diseases previously deemed untreatable.

In 2024, regulatory approvals reached a milestone, with agencies such as the U.S. Food and Drug Administration (FDA), China's National Medical Products Administration (NMPA), the European Medicines Agency (EMA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA) all endorsing thirteen novel CGTs. Noteworthy developments include the inaugural CRISPR therapy, the first MRI-guided intracranial AAV delivery gene therapy, and a pioneering tumor infiltration lymphocyte therapy. These breakthroughs have ushered in a new era of innovation in gene editing and cellular technology applications.

Market dynamics suggest that increasing clinical and commercial activities will propel the demand for cell and gene therapy tools and reagents forward.

Report Scope

The report offers comprehensive insights into market segmentation by product type, application, and end-user. Product categories encompass vectors, GMP proteins, bioreactors, and more, while applications span cancer and rare diseases among other conditions. The report evaluates the competitive market landscape across major global regions, including North America, Europe, and Asia-Pacific.

The study details the current market size and forecasts growth, presenting a thorough market analysis via 77 data tables and 55 additional tables. It explores evolving technologies, examining both opportunities and challenges within the market. Focus areas include regulatory conditions, reimbursement scenarios, and emerging environmental, social, and corporate governance (ESG) trends. Insights into competitive dynamics are provided, with key market participants analyzed in terms of their product portfolios and strategic priorities.

The report also profiles leading companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG, highlighting their contribution and market positioning within this rapidly advancing sector.

Key Attributes

Key Topics Covered

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in Global Market for Cell and Gene Therapy Tools and Reagents: An ESG Perspective

Chapter 9 Appendix

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/mwlxo5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment